Sedana Medical AB (FRA:7D2A)
€ 1.066 0.054 (5.34%) Market Cap: 110.49 Mil Enterprise Value: 91.51 Mil PE Ratio: 0 PB Ratio: 1.15 GF Score: 65/100

Q1 2022 Sedana Medical AB (publ) Earnings Call Transcript

Apr 28, 2022 / 11:30AM GMT
Release Date Price: €3.21 (-29.55%)
Operator

Welcome to the Sedana Medical Audiocast and Teleconference Q1 2022. (Operator Instructions)

Today, I'm pleased to present CEO and President, Johannes Doll; CFO, Johan Spetz; CMO, Peter Sackey. Please go ahead with your meeting.

Johannes Doll;publ;CEO;President
Sedana Medical AB

()-&

Thank you. Good afternoon, everyone, and Good morning to those of you dialing in from the U.S. Thank you very much for taking time with us today, and welcome to Sedana Medical Q1 report 2022.

Let's get into it. I will take the first part of the presentation and talk about the business and specifically about the sales performance and the different geographies. I would spend some time explaining the drivers behind that performance and also try to be as clear as possible what you can expect in the short-term and in the longer-term. Then Peter Sackey, who is dialing in from the U.S. today, will take over to give an update on the clinical trials in the United States that are now underway. And lastly, Johan Spetz, our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot